...
首页> 外文期刊>Vaccine >Current situation of tuberculosis in Japan and requirement for new vaccine
【24h】

Current situation of tuberculosis in Japan and requirement for new vaccine

机译:日本结核病的现状和对新疫苗的需求

获取原文
获取原文并翻译 | 示例
           

摘要

“Tuberculosis (TB) still remains a major life-threatening disease in the world.” It is almost the stereotype sentence describing the situation of TB in the world today. World Health Organisation reports that approximately 8.7 million new TB cases are estimated globally, and 1.4 million patients die from the disease 1. In the same report, they estimate approximately 630,000 multi-drug resistant TB (MDR-TB) cases in 2011. Furthermore, it is estimated that approximately 1/3 of world's population is already infected by Mycobacterium tuberculosis. The TB infected people, so called latent tuberculosis infection (LTBI), will serve as a reservoir of active disease. These figures evidence the first sentence and will require proper countermeasures to sort out the current and future health problems.
机译:“结核病(TB)仍然是世界上威胁生命的主要疾病。这几乎是描述当今世界结核病状况的刻板印象。世界卫生组织报告称,全球估计约有870万新发结核病病例,140万患者死于该病[1]。在同一份报告中,他们估计2011年约有630,000例耐多药结核病(MDR-TB)病例。此外,据估计,世界上大约1/3的人口已经感染了结核分枝杆菌。结核病感染者,即所谓的潜伏性结核感染(LTBI),将成为活动性疾病的宿主。这些数字证明了第一句话,需要采取适当的对策来解决当前和未来的健康问题。

著录项

  • 来源
    《Vaccine》 |2014年第2期|304-305|共2页
  • 作者

    Mitarai Satoshi;

  • 作者单位

    Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, 3-1-24 Matsuyama, Kiyose, Tokyo 204-8533, Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类 医学免疫学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号